Inhibikase Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $8.4k | 5.0k | 1.67 |
| 2025-03-31 | $56k | 26k | 2.19 |
| 2024-12-31 | $251k | 77k | 3.25 |